AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria

Insights into the quest to find an effective treatment for this socially painful condition

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Is now finally the time for Alzheimer’s drug development to shine?

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

Pharma sponsors are increasingly looking to CDMOs to help reduce risk and push projects forward.

The remarkable story of gene therapy drug development during the 1990s and early 2000s.